170 related articles for article (PubMed ID: 22643084)
1. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice.
Chen Y; Guan Y; Zhang Z; Liu H; Wang S; Yu L; Wu X; Wang X
Neurol Res; 2012 May; 34(4):390-9. PubMed ID: 22643084
[TBL] [Abstract][Full Text] [Related]
2. Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice.
Chen Y; Guan Y; Liu H; Wu X; Yu L; Wang S; Zhao C; Du H; Wang X
Biochem Biophys Res Commun; 2012 Apr; 420(2):397-403. PubMed ID: 22426476
[TBL] [Abstract][Full Text] [Related]
3. Expression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice.
Li X; Guan Y; Chen Y; Zhang C; Shi C; Zhou F; Yu L; Juan J; Wang X
Int J Clin Exp Pathol; 2013; 6(7):1245-60. PubMed ID: 23826406
[TBL] [Abstract][Full Text] [Related]
4. Wnt Signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice.
Yu L; Guan Y; Wu X; Chen Y; Liu Z; Du H; Wang X
Neurochem Res; 2013 Sep; 38(9):1904-13. PubMed ID: 23784673
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of IGF-I and GSK in the spinal cord of Kii and Guamanian ALS patients.
Kihira T; Suzuki A; Kondo T; Wakayama I; Yoshida S; Hasegawa K; Garruto RM
Neuropathology; 2009 Oct; 29(5):548-58. PubMed ID: 19323791
[TBL] [Abstract][Full Text] [Related]
6. Increased phospho-adducin immunoreactivity in a murine model of amyotrophic lateral sclerosis.
Shan X; Hu JH; Cayabyab FS; Krieger C
Neuroscience; 2005; 134(3):833-46. PubMed ID: 15994023
[TBL] [Abstract][Full Text] [Related]
7. The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice.
Ahn SW; Kim JE; Park KS; Choi WJ; Hong YH; Kim SM; Kim SH; Lee KW; Sung JJ
J Neurol Sci; 2012 Sep; 320(1-2):1-5. PubMed ID: 22698482
[TBL] [Abstract][Full Text] [Related]
8. DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.
Larrodé P; Calvo AC; Moreno-Martínez L; de la Torre M; Moreno-García L; Molina N; Castiella T; Iñiguez C; Pascual LF; Mena FJM; Zaragoza P; Y Cajal SR; Osta R
Mol Neurobiol; 2018 Jan; 55(1):1-12. PubMed ID: 28840473
[TBL] [Abstract][Full Text] [Related]
9. Multiplexed chemogenetics in astrocytes and motoneurons restore blood-spinal cord barrier in ALS.
Ouali Alami N; Tang L; Wiesner D; Commisso B; Bayer D; Weishaupt J; Dupuis L; Wong P; Baumann B; Wirth T; Boeckers TM; Yilmazer-Hanke D; Ludolph A; Roselli F
Life Sci Alliance; 2020 Nov; 3(11):. PubMed ID: 32900826
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of insulin-like growth factor-II receptor in reactive astrocytes in the spinal cord of amyotrophic lateral sclerosis transgenic rats.
Dagvajantsan B; Aoki M; Warita H; Suzuki N; Itoyama Y
Tohoku J Exp Med; 2008 Apr; 214(4):303-10. PubMed ID: 18441505
[TBL] [Abstract][Full Text] [Related]
11. Wnt Signaling Alterations in the Human Spinal Cord of Amyotrophic Lateral Sclerosis Cases: Spotlight on Fz2 and Wnt5a.
González-Fernández C; Gonzalez P; Andres-Benito P; Ferrer I; Rodríguez FJ
Mol Neurobiol; 2019 Oct; 56(10):6777-6791. PubMed ID: 30924074
[TBL] [Abstract][Full Text] [Related]
12. Wnt Signaling Alteration in the Spinal Cord of Amyotrophic Lateral Sclerosis Transgenic Mice: Special Focus on Frizzled-5 Cellular Expression Pattern.
González-Fernández C; Mancuso R; Del Valle J; Navarro X; Rodríguez FJ
PLoS One; 2016; 11(5):e0155867. PubMed ID: 27192435
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue.
Casula M; Iyer AM; Spliet WG; Anink JJ; Steentjes K; Sta M; Troost D; Aronica E
Neuroscience; 2011 Apr; 179():233-43. PubMed ID: 21303685
[TBL] [Abstract][Full Text] [Related]
14. Regulation of system x(c)- in the SOD1-G93A mouse model of ALS.
Albano R; Liu X; Lobner D
Exp Neurol; 2013 Dec; 250():69-73. PubMed ID: 24041987
[TBL] [Abstract][Full Text] [Related]
15. Selective overexpression of gamma1 laminin in astrocytes in amyotrophic lateral sclerosis indicates an involvement in ALS pathology.
Wiksten M; Väänänen A; Liesi P
J Neurosci Res; 2007 Jul; 85(9):2045-58. PubMed ID: 17554784
[TBL] [Abstract][Full Text] [Related]
16. Increased Expression of 15-Hydroxyprostaglandin Dehydrogenase in Spinal Astrocytes During Disease Progression in a Model of Amyotrophic Lateral Sclerosis.
Miyagishi H; Kosuge Y; Takano A; Endo M; Nango H; Yamagata-Murayama S; Hirose D; Kano R; Tanaka Y; Ishige K; Ito Y
Cell Mol Neurobiol; 2017 Apr; 37(3):445-452. PubMed ID: 27140190
[TBL] [Abstract][Full Text] [Related]
17. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
[TBL] [Abstract][Full Text] [Related]
18. Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
Zhang J; Ito H; Wate R; Ohnishi S; Nakano S; Kusaka H
Acta Neuropathol; 2006 Dec; 112(6):673-80. PubMed ID: 16957927
[TBL] [Abstract][Full Text] [Related]
19. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
[TBL] [Abstract][Full Text] [Related]
20. Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model.
Wang R; Yang B; Zhang D
Glia; 2011 Jun; 59(6):946-58. PubMed ID: 21446050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
